4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-018021
Chief Medical Officer sold 3,350 shares at $11.43 ($38,291)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2022-03-08 | Sale | −3,350 | $11.43 | $38,291 | 17,171 | D: show line 1 in the form |
| Open-market sales · 3,350 sh · avg $11.43 · $38,291 | |||||||
Loading xslF345X03/doc4.xml…